Mission: The mds foundation, inc. (mdsf) is an international organization devoted to the support and education of patients and healthcare providers with innovative research in the fields of mds and related myeloid neoplasms in order to accelerate progress leading to the control and cure of these diseases.
Programs: The foundation continued its extensive patient advocacy outreach initiatives in 2017.The foundation staff communicates daily with patients and caregivers providing support and education regarding the myelodysplastic syndromes in the following formats: patient information via the foundation's new "building blocks of hope" initiative, mds foundation newsletters, and through the mds foundation website and social media campaigns. On-site patient liaison support is also provided including referrals to the mds centers of excellence, providing information on current treatment options and available clinical trials, responses to email and social media inquiries, and providing a connection between mds patients upon request. In addition, educational symposia are conducted for associations such as the american society of hematology and the oncology nursing society. An mds foundation bi-annual conference is conducted as well. These informative and interactive symposia are directed toward hematologists and nurses working in hematology, as well as fellows in hematology, pharmacists working with mds patients and health professonals working in the field of mds patient care and treatment.
educational symposia and a bi-annual conference are conducted for several societies and associations such as the american society of hematology and the oncology nursing society. These informative and interactive symposia are aimed at hematologists and nurses working in hematology as well as fellows in hematology, pharmacists working with mds patients and allied health professionals working in the field of mds patient care and treatment.
the mds foundation provides research grants for scientific investigators. The foundation is dedicated to furthering the research into mds and will invite young investigators to submit proposals for either basic research or clinical management into the causation, epidemiology, molecular biology, cytogenetics, morphology, prognosis and management of the myelodysplastic syndromes. In addition, the foundation sponsors international working groups of scientists and physicians to further diagnostic, prognostic and treatment techniques. The foundation has also established a procedure for creating awareness of clinical trials in the field of mds as well as assisting in the clinical trial recruitment process by utilizing its outreach to hematologists worldwide who can refer patients into these protocols.